Christopher Haqq - Title: Executive Vice President, Head of R&D and Chief Medical Officer at Elicio Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Title: Executive Vice President, Head of R&D and Chief Medical Officer
Stock Symbol
ELTX on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Christopher Haqq since 11/21/2023

Holdings reported by Christopher Haqq for Elicio Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Stock Option (Right to Buy) 28.2K Sep 30, 2024 Direct Common Stock

Transactions reported by Christopher Haqq for Elicio Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.